• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER Back to Search Results
Model Number H7493960820400
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Itching Sensation (1943); Rash (2033); Discomfort (2330)
Date of Event 11/20/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that upper chest discomfort, pruritus and rash occurred.A 4.00 x 20 mm agent drug-coated balloon (dcb) was used in the patient's saphenous vein graft.Following the procedure, the patient developed an upper chest rash with associated pruritus.The physician prescribed antihistamines (zyrtec) and a beta blocker to manage the symptoms; however, the patient has continued to experience discomfort since (b)(6) 2025.
 
Event or Problem Description
It was reported that upper chest discomfort, pruritus and rash occurred.A 4.00 x 20 mm agent drug-coated balloon (dcb) was used in the patient's saphenous vein graft.Following the procedure, the patient developed an upper chest rash with associated pruritus.The physician prescribed antihistamines (zyrtec) and a beta blocker to manage the symptoms; however, the patient has continued to experience discomfort since (b)(6) 2025.
 
Additional Manufacturer Narrative
G1: added mfr site facility name, address 1, city, code and country.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT?
Common Device Name
DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key23805223
Report Number2124215-2025-90889
Device Sequence Number7622326
Product Code OOB
UDI-Device Identifier00191506014841
UDI-Public(01)00191506014841
Combination Product (Y/N)Y
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
P230035
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberH7493960820400
Device Catalogue NumberH7493960820400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/20/2025
Supplement Date Received by Manufacturer11/20/2025
Initial Report FDA Received Date12/15/2025
Supplement Report FDA Received Date12/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-